Insider filing · ADPT
Michelle Renee Griffin
Director
profile →
Adaptive Biotechnologies Corporation
ADPT · Healthcare · 69 filings in 24 months
ticker →
Michelle Renee Griffin sold $261K of Adaptive Biotechnologies (ADPT)
Executed Mar 13 2025, disclosed Mar 17 2025, 4 days later.
Value, as filed
$261K
36,291 sh × $7.19
Executed
Mar 13 2025
the trade date, as filed
Disclosed
Mar 17 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MGMichelle Renee Griffin (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $1.1M of ADPT (52,084 sh × $20.18, as filed), executed Jun 25.
The name
ADPTHealthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michelle Renee Griffin in ADPT
ADPTSALE
Adaptive Biotechnologies Corporation
$1.1M52,084 sh × $20.18
Exec Jun 25
Filed Jun 29 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $214K
15,394 sh × $13.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $735K
48,044 sh × $15.30
Exec Mar 3
Filed Mar 5 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $124K
15,664 sh × $7.94
Exec Mar 6 2025
Filed Mar 6 2025 · 5:30 PM ET